• TRM (USD/COP)COP 3,461.92 +1.37% +COP 46.82Colombia's official exchange rate (Financial Superintendence), valid Nov 21 to Nov 23
  • EuroCOP 3,804.64 +1.37% +COP 51.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
  • Mexican pesoCOP 181.56 +1.37% +COP 2.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote

Ernexa Therapeutics adds monthly cash compensation for its CFO, Mark J. Keeley

FinanceInternationalTradingViewAI summary
Image: TradingView

Ernexa Therapeutics added monthly cash compensation to the consulting agreement of its CFO, Mark J. Keeley, effective November 9, 2026. According to the Form 8-K filed with the SEC on November 19, 2026, the amendment sets $5,000 per month, payable on the last day of each month and prorated for November 2026. The existing equity-based compensation and all other terms of the agreement remain unchanged.

In 35 seconds

  • The amendment to Mark J. Keeley's consulting agreement adds cash compensation effective November 9, 2026.
  • The payment is $5,000 per month, on the last day of each month and prorated for November 2026.
  • Equity-based compensation and the rest of the agreement's terms are unchanged.
Read the full story at TradingView

IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading